Skip to main content
Father's Day Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

Summary by Joplin Globe
FOSTER CITY, Calif. & WILMINGTON, Del.--(BUSINESS WIRE)--Jun 14, 2026-

4 Articles

Joplin GlobeJoplin Globe
+3 Reposted by 3 other sources
Center

Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

FOSTER CITY, Calif. & WILMINGTON, Del.--(BUSINESS WIRE)--Jun 14, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Carroll County Mirror-Democrat broke the news in Mount Carroll, United States on Sunday, June 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Foster City icon

Foster City

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal